JingZhouHouMD

PubMed

• Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
  Normolle, D., Bovbjerg, D., Im, A., Quann, K., Agha, M., Raptis, A., Redner, R., Hou, J., Farah, R., Dorritie, K., Sehgal, A., Aggarwal, N., Herman, J., Lontos, K., Bo...> ;American Journal of Hematology. 2024 Mar 1
• Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.
  Jacqueline C Barrientos, Ayed O Ayed, Agnes Cha, Senxi Du, Bruno Fang, Ryan Hall, Stanley M Marks, Eileen Peng, Joanna M Rhodes, Kellie Ryan, Sharon B Winters, Percy L...> ;Targeted Oncology. 2023 Sep 1
• 3 citations
  Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
  Loretta J Nastoupil, Georg Hess, Miguel A Pavlovsky, Iwona Danielewicz, Jane Freeman, Alejandro Martin García-Sancho, Valeria Glazunova, Andrew Grigg, Jing-Zhou Hou, A...> ;Blood Advances. 2023 Nov 28
• 3 citations
  A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
  Brian A Jonas, Jing-Zhou Hou, Gail J Roboz, Caroline L Alvares, Deepa Jeyakumar, John R Edwards, Harry P Erba, Richard J Kelly, Christoph Röllig, Walter Fiedler, Deann...> ;Hematological Oncology. 2023 Oct 1
• Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
  Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2023 Mar 1
• 12 citations
  Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.
  Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Inho Kim, Jan Novak, Rebecca Champion, Walter Fiedler, Maria Pagoni, Julie Berger...> ;Blood. 2022 Dec 22
• A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
  Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2022 Dec 1
• 6 citations
  Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.
  Donna M Posluszny, Dana H Bovbjerg, Karen L Syrjala, Mounzer Agha, Rafic Farah, Jing-Zhou Hou, Anastasios Raptis, Annie P Im, Kathleen A Dorritie, Michael M Boyiadzis,...> ;Transplantation and Cellular Therapy. 2022 Mar 1
• 14 citations
  Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
  Jing-Zhou Hou, Kellie Ryan, Senxi Du, Bruno S. Fang, Stanley M. Marks, Ray Page, Eileen Peng, Keith Szymanski, Sharon Winters, Hannah Le> ;Future Oncology. 2021 Nov 16
• 1 citations
  Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
  Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, V. E. Ivanov, Inho Kim, Jan Novák, Don A. Stevens, Walter Fiedler, Maria Pagoni, Julie Bergeron, ...> ;Blood Cancer Journal. 2021 Oct 26
• 17 citations
  6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150).
  Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, V. E. Ivanov, Inho Kim, Jan Novák, Don A. Stevens, Walter Fiedler, Maria Pagoni, Julie Bergeron, ...> ;Blood Cancer Journal. 2021 Oct 1
• 5 citations
  A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
  Christi McKeown, Asha Ricciuti, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James ...> ;Supportive Care in Cancer. 2021 Sep 25
• 35 citations
  Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.
  Jing Zhou Hou, Jing Christine Ye, Jeffrey J. Pu, Hongtao Liu, Wei Ding, Hong Zheng, Delong Liu> ;Journal of Hematology & Oncology. 2021 Apr 21
• 3 citations
  Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.
  Arisha Patel, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James M. Rossetti, Melis...> ;Oncology Research. 2021 Sep 7
• 361 citations
  Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
  Andrew H. Wei, Pau Montesinos, VV Ivanov, Courtney D. DiNardo, Jan Novák, Kamel Laribi, Inho Kim, Don A. Stevens, Walter Fiedler, Maria Pagoni, Olga Samoilova, Yu Hu, ...> ;Blood. 2020 Jun 11
• 424 citations
  Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.
  Andrew H. Wei, Stephen A. Strickland, Jing Zhou Hou, Walter Fiedler, Tara L. Lin, Roland B. Walter, Anoop K Enjeti, Ing Soo Tiong, Michael R. Savona, Sangmin Lee, Bren...> ;Journal of Clinical Oncology. 2019 Mar 20
• 6 citations
  Location matters in early stage nodal diffuse large B-cell lymphoma
  Konstantinos Lontos, Anastasia Tsagianni, Jian-Min Yuan, Daniel P. Normolle, Michael Boyiadzis, Jing-Zhou Hou, Steven H. Swerdlow, Kathleen A. Dorritie> ;Leukemia & Lymphoma. 2019 Jan 1
• 14 citations
  Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen.
  Donna M. Posluszny, Dana H. Bovbjerg, Mounzer Agha, Jing-Zhou Hou, Anastasios Raptis, Michael Boyiadzis, Jacqueline Dunbar-Jacob, Richard Schulz, Mary Amanda Dew> ;Psycho-Oncology. 2018 Jan 1
• 109 citations
  Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.
  Michael Boyiadzis, Mounzer Agha, Robert L. Redner, Alison R. Sehgal, Annie Im, Jing-Zhou Hou, Rafic Farah, Kathleen A. Dorritie, Anastasios Raptis, Seah H. Lim, Hong W...> ;Cytotherapy. 2017 Oct 1
• 1 citations
  Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation
  Konstantinos Lontos, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James M. Rossetti...> ;Clinical Transplantation. 2017 Sep 1
• Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia
  Matthew J. Lim, Aya Agha, Annie Im, Anastasios Raptis, Jing Z. Hou, Michael Boyiadzis, Alison R. Sehgal, Robert L. Redner, Kathleen A. Dorritie, Stanley S. Marks, Moun...> ;Hematological Oncology. 2018 Apr 1
• 19 citations
  Leukapheresis in patients newly diagnosed with acute myeloid leukemia
  Vipin Villgran, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Seah H. Lim, Robert L. Redner, Annie Im, Alison R. Sehgal, Kathleen A. Dorritie, Joseph E....> ;Transfusion and Apheresis Science. 2016 Oct 1
• 1 citations
  ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia.
  Bobbi Hartsock, Matthew J. Lim, Christine G. Roth, Nepheli Raptis, David Weber, Alison R. Sehgal, Michael Boyiadzis, Anastasios Raptis, Jing-Zhou Hou, Annie Im, Kathle...> ;Leukemia Research. 2016 Sep 1
• 12 citations
  Peri‐transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant
  Aya Agha, Alison R. Sehgal, Matthew J. Lim, David Weber, Jing-Zhou Hou, Rafic Farah, Anastasios Raptis, Annie Im, Kathleen A. Dorritie, Stanley M. Marks, Mounzer Agha,...> ;American Journal of Hematology. 2016 Mar 1
• Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.
  Sara J. Lim, Matthew J. Lim, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Stanley M. Marks, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, Mounzer Agha, Seah H. Lim> ;European Journal of Haematology. 2016 Jan 1
• Join now to see all